Asian Journal of Dairy and Food Research

Asian Journal of Dairy and Food Research cover
Volume 44 · Issue 5 · 2025/05/14

Interplaying Correlation of Some Genetic and Inflammatory Factors among Patients with Polycythemia Vera

Yusra Ghiath
Baan Abdulatif Mtashar
Noor AL-Huda Salah AL-Zuhairy
Mohanad Salam Hussein
Ahmed Flayyih Hasan
362 Views

Submitted

2024/12/25

First Online

2025/05/14

doi

10.18805/ajdfr.DRF-492

Cite article - Yusra Ghiath, Baan Abdulatif Mtashar, Noor AL-Huda Salah AL-Zuhairy, Mohanad Salam Hussein, Ahmed Flayyih Hasan. (2025). Interplaying Correlation of Some Genetic and Inflammatory Factors among Patients with Polycythemia Vera. Asian Journal of Dairy and Food Research. 44(5): 768–773. doi: 10.18805/ajdfr.DRF-492

Abstract

Background: Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. A key feature of PV is the dysregulation of cytokine networks, with elevated levels of various pro-inflammatory cytokines contributing to disease progression. The JAK2 mutation, a common genetic driver of PV, stimulates the production of these cytokines, leading to increased cell proliferation, inhibited apoptosis and inflammation. Estimation of IL-12 and IL-21 Level and study the correlation between of theses cytokine with JAK2 V617F and hematological parameters.

Methods: This study investigated 60 patients diagnosed with polycythemia vera (PV) at the National Center of Hematology between January 2023 and July 2024. The patient group consisted of 33 females and 27 males, with ages ranging from 18 to 75 years. Detection JAK2 V617F using Poly chain reaction (PCR) as well as estimation of IL-12 and IL-21 by sandwich ELISA technique.

Result: In this Study 31 of PV patients detected as JAK2 V 617F Negative while 29 patients were positive. Also, this study examined the role of IL-12 and IL-21 in polycythemia vera (PV). Patients with the JAK2 V617F mutation had significantly higher IL-12 levels, suggesting a strong association. However, no significant differences were found in IL-21 levels between groups. Additionally, WBC count and platelets count were positively correlated with IL-21.

References

  1. Abass, S.F., Hussein, M.S., Hasan, A.F., Al-Dulimi, A.G. and El-Wahsh, H.M. (2025). Effect of bee venom ( Apis mellifera ) on liver damage in mice with Ehrlich ascites carcinoma. Regulatory Mechanisms in Biosystems . 33(1): e25040- e25040. Alyasiri, T., Hameed, H.M. and Hasan, A.F. (2024). The effects of bisphenol A of polycarbonate plastics on various blood and fertility parameters, along with histological changes in male albino rats. Asian Journal of Dairy and Food Research . 44(2): 313-319. doi: 10.18805/ajdfr.DRF-435 . Al-Maliki, N.S., Jumaah, Y.H., Hameed, H.M., Khudhair, O.E., Hadid, M.A. and Hasan, A.F. (2025). Evalua cells and its role in chemotherapy resistance in Iraqi patients with acute myeloid leukemia. Opera Medica et Physiologica . 12(1): 30-37. Barbui, T., Vannucchi, A M., De Stefano, V., Carobbio, A., Ghirardi, A., Carioli, G. and Rambaldi, A. (2023). Ropeginterferon versus standard therapy for low-risk patients with polycythemia vera. NEJM evidence . 2(6): EVIDoa2200335. Behrens, K. and Alexander, W.S. (2018). Cytokine control of megaka- ryopoiesis. Growth Factors . 36(3-4): 89-103. Benbarche, S., Strassel, C., Angénieux, C., Mallo, L., Freund, M., Gachet, C. and de La Salle, H. (2017). Dual role of IL-21 in megaka- ryopoiesis and platelet homeostasis. Haematologica . 102(4): 637. Biewenga, M., Heidt, S., Vergunst, M., Marijnissen, C.M., de Man, R.A., van der Eijk, A.A. and van Hoek, B. (2022). B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis. JHEP Reports . 4(5): 100460. Braun, L.M. and Zeiser, R. (2020). Immunotherapy in myeloproliferative diseases. Cells . 9(6): 1559. Cacemiro, M.D.C., Cominal, J.G., Berzoti-Coelho, M.G., Tognon, R., Nunes, N.D.S., Simoes, B. and Castro, F.A.D. (2020). Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports . 10(1): 7032. Cattaneo, D. and Iurlo, A. (2021). Immune dysregulation and infectious complications in MPN patients treated with JAK inhibitors. Frontiers in Immunology . 12: 750346. Dupont, S., Massé, A., James, C., Teyssandier, I., Lécluse, Y., Larbret, F. and Delhommeau, F. (2007). The JAK2 617V> F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood. The Journal of the American Society of Hematology . 110(3): 1013-1021. Hameed, H.M., Razooki, Z.H. and Hasan, A.F. (2024). Therapeutic Effect of essential oils ( Citrus sinensis ) against Ehrlich Ascites Model Induced Renal Toxicity in Female Mice. Hasan, A.F., Hameed, H.M., Hadid, M.A. and Tousson, E. (2024). Impact of chia (Salvia hispanica) seeds extract on ehrlich ascites model induced kidney toxicity in female mice. Asian Journal of Dairy and Food Research . 43(4). doi: 10.18805/ajdfr.DRF-397 . Hoermann, G., Greiner, G. and Valent, P. (2015). Cytokine regulation of microenvironmental cells in myeloproliferative neoplasms. Mediators of Inflammation . 2015(1): 869242. Holdsworth, S.R. and Gan, P.Y. (2015). Cytokines: Names and numbers you should care about. Clinical journal of the American Society of Nephrology . 10(12): 2243-2254. Jahandideh, B., Derakhshani, M., Abbaszadeh, H., Movassaghpour, A.A., Mehdizadeh, A., Talebi, M. and Yousefi, M. (2020). The pro-Inflammatory cytokines effects on mobilization, self-renewal and differentiation of hematopoietic stem cells. Human Immunology . 81(5): 206-217. Jain, A., Deo, P., Sachdeva, M.U.S., Bose, P., Lad, D., Prakash, G. and Malhotra, P. (2021). Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis. Blood Cells, Molecules and Diseases . 89: 102565. Lanikova, L., Babosova, O., Swierczek, S., Wang, L., Wheeler, D.A., Divoky, V. and Prchal, J.T. (2016). Coexistence of gain-of- function JAK2 germ line mutations with JAK2 V617F in polycythemia vera. Blood, The Journal of the American Society of Hematology . 128(18): 2266-2270. Pardanani, A., Begna, K., Finke, C., Lasho, T. and Tefferi, A. (2011). Circulating levels of MCP 1, sIL 2R, IL 15 and IL 8 predict anemia response to pomalidomide therapy in myelofibrosis. American Journal of Hematology . 86(4): 343-345. Patterson, S.D. and Copland, M. (2023). The bone marrow immune microenvironment in CML: Treatment responses, treatment- free remission and therapeutic vulnerabilities. Pesce, S., Greppi, M., Ferretti, E., Obino, V., Carlomagno, S., Rutigliani, M. and Marcenaro, E. (2020). miRNAs in NK cell-based immune responses and cancer immunotherapy. Frontiers in Cell and Developmental Biology . 8: 119. Pourcelot, E., Trocme, C., Mondet, J., Bailly, S., Toussaint, B. and Mossuz, P. (2014). Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications. Experimental hematology . 42(5): 360-368. Rentschler, M., Braumüller, H., Briquez, P.S. and Wieder, T. (2022). Cytokine- induced senescence in the tumor microenvironment and its effects on anti-tumor immune responses. Cancers . 14(6): 1364. Spivak, J.L., Considine, M., Williams, D.M., Talbot Jr, C.C., Rogers, O., Moliterno, A.R. and Ochs, M.F. (2014). Two clinical phenotypes in polycythemia vera. New England Journal of Medicine . 371(9): 808-817. Tefferi, A., Vaidya, R., Caramazza, D., Finke, C., Lasho, T. and Pardanani, A. (2011). Circulating interleukin (IL)-8, IL-2R, IL-12 and IL-15 levels are independently prognostic in primary myelofibrosis: A comprehensive cytokine profiling study. Journal of Clinical Oncology . 29(10): 1356-1363. Tefferi, A., Vannucchi, A.M. and Barbui, T. (2021). Polycythemia vera: Historical oversights, diagnostic details and therapeutic views. Leukemia . 35(12): 3339-3351. Ullrich, K.A., Schulze, L.L., Paap, E.M., Müller, T.M., Neurath, M.F. and Zundler, S. (2020). Immunology of IL-12: An update on functional activities and implications for disease. EXCLI Journal . 19: 1563. Vaidya, R., Gangat, N., Jimma, T., Finke, C.M., Lasho, T.L., Pardanani, A. and Tefferi, A. (2012). Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance and comparison with myelofibrosis. American Journal of Hematology . 87(11): 1003-1005. Vardiman, J.W. (2010). The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms. Chemico-biological Interactions . 184(1-2): 16-20. Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A. and Bloomfield, C.D. (2009). The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood. The Journal of the American Society of Hematology. 114(5): 937-951. Verstovsek, S., Kantarjian, H., Mesa, R.A., Pardanani, A.D., Cortes-Franco, J., Thomas, D.A. and Tefferi, A. (2010). Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. New England Journal of Medicine . 363(12): 1117-1127. Verstovsek, S., Mesa, R.A., Gotlib, J., Levy, R.S., Gupta, V., DiPersio, J.F. and Kantarjian, H.M. (2012). A double-blind, placebo- controlled trial of ruxolitinib for myelofibrosis. New England Journal of Medicine . 366(9): 799-807. Waksal, J.A., Wagner, N.E. and Mascarenhas, J.O. (2024). Risk factors for disease progression and treatment goals in polycythemia vera. Risk. 22(1). Wang, Y. and Zuo, X. (2019). Cytokines frequently implicated in myeloproli- ferative neoplasms. Cytokine: X. 1(1): 100005. World Health Organization (Ed.). (2008). World Health Statistics 2008. World Health Organization. Yahya, A., Adil Obaid, W., Mohammed Hameed, O. and Hasan, A.F. (2024). Histopathological and immunohistochemical studies on the effects of silver oxide nanoparticles (AgNPs) on male rats’ liver. Journal of Bioscience and Applied Research . 10(3): 392-398. Yoon, J.S., Kang, H., Jekarl, D.W., Lee, S.E. and Oh, E.J. (2024). Diagnostic performance of serum erythropoietin to discriminate polycythemia vera from secondary erythrocytosis through established subnormal limits. Diagnostics . 14(17): 1902.
EDITORIAL BOARD

Guided by Experienced Academic Leadership

Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.

View Full Board
Harjinder Singh
Chief Editor

Harjinder Singh

DirectorMassey Institute of Food Science and Technology, NEW ZEALAND

Tanweer Alam
Associate chief editor

Tanweer Alam

DirectorIndian Institute of Packaging, Mumbai, Maharashtra, INDIA

Mridula Devi
Editor

Mridula Devi

DirectorICAR-Central Institute for Women in Agriculture, Bhubaneswar, Odisha, India

A. Elango
Editor

A. Elango

DeanVeterinary College and Research Institute, Salem, Tamil Nadu Veterinary and Animal Sciences University, T.N., INDIA